Sino-report
Home Sign in Research report Data Center Industry News Custom Research About us
Research report:                          Automotive  |  Electronics  |  Mechanical&Automation  |  New Energy  |  Medical  |  Advanced Materials  |  Building Products  |  Transportation  |  Communication  |  Chemical  |  Finance  |  IT Industry  |  Food  |  Home Appliances  |  Forestry  |  Agriculture  |  Textile  |  Culture Industry  |  Consumer goods  |  Others  |
 Home > Industry News > Medical > Text
Tasly Group announced a $40 million investment plan in US
Author:Sino-report    Source:China Daily    Number of clicks :     Update time:2011-06-03 10:55
Sino-report News Center Jun 2011

SHANGHAI - The traditional Chinese medicine (TCM) industry looks likely to gain an overseas presence by tapping into the US market.
Tasly Group Co Ltd, one of China's leading biopharmaceutical companies, announced on Thursday a $40 million investment plan in TCM product research at a new operation in the US state of Maryland.
This is the latest plan by a Chinese medicine manufacturer to gain a stronger international presence, after a European Union regulation in effect removed TCMs from the European market.
By opening a production facility and training center in Maryland, Tasly intends to leverage the state's vast bioscience resources as it prepares for Phase III clinical trials of its TCM product Compound Danshen Dripping Pills (CDDP).
The investment plan is an effort to put the first US Food and Drug Administration-approved TCM medication on the market, according to Yan Xijun, chairman of Tasly.
"We think it is an incredible opportunity for Tasly to innovate new products and introduce them to the US market. This also marks an important chapter in the globalization of traditional Chinese medicine," Yan said at the signing ceremony for the investment plan in Shanghai.
Maryland Governor Martin O'Malley said the cooperation reflects a mutual Chinese and US aspiration to advance TCM on the global market.
"Traditional Chinese medicines are famous for their lack of side effects and provide better treatment. We are excited to figure out ways to combine the West and East and contribute to the internationalization of the medicine," O'Malley said.
CDDP, developed to treat and prevent coronary disease, is the first Chinese combination medicine to complete Phase II clinical studies both in China and abroad. If all goes well with the Phase III trials, it is expected to be formally launched as early as 2014.
Anticipating possible concerns of Western users, Yan said modern TCM products are made from the same traditional ingredients, but are packaged in capsules like chemical medications.
During clinical trials, tests are conducted to ensure the safety of the medication and identify any adverse reactions. All medicines approved for the US market must undergo three phases of trials, said Song Ruilin, executive president of the China Pharmaceutical Industry Research and Development Association.
"TCM is based on experience, rather than experiments. To get an operating license, manufacturers must present detailed results of experiments showing that their products meet the safety, purity and effectiveness requirements. This is the biggest hurdle for Chinese herbal medicine producers," Song told China Daily.
The European Union imposed strict regulations on herbal medicine products on May 1, significantly raising the threshold for market access. No Chinese company was able to meet the new standards.
Tasly says it will strive to provide high quality TCM products for the US and European markets and play a part in regulating TCM packaging and manufacturing overseas.
Tasly is also attracted by Maryland's proximity to Washington DC, where federal authorities, including the FDA, are concentrated, Yan said.

 

Order Online
Contact Us
Tel: 400-988-9999
Fax:010-82889999
Phone :+8615313587056
Email:Sale@sino-report.com
Email:Cousult@sino-report.com
Online Consultation
MSN :Sino-report@hotmail.com
MSN :Sino-report@foxmail.com
Skype: Please Please
Latest Reports
  More>>
[Medical] Medical device manufacturers display their latest technology
[Medical] Initiative helps boost traditional Chinese medicine
[Medical] Cancer drug prices set to drop
[Medical] Traditional Chinese medicine exports rebound in 2017
Popular reports
  More>>
Medical device manufacturers display their latest technology
Industry Data
  More>>
China opens market to Kenya's agricultural products
China's publishing industry booming over past 40 years
Industrial Production Operation in July 2018
Total Retail Sales of Consumer Goods in July 2018
National Real Estate Development and Sales in the First Seven Months of 2018
NSDP/SDDS for the People's Republic of China
Market Price of Important Means of Production in Circulation, July 01-10, 2018
In the first five months of 2018, the profits made by industrial enterprises above the designated siz
Purchasing Managers Index for June 2018
Market Price of Important Means of Production in Circulation, June 21-30, 2018
In global EV battery shipments during Jan - Apr 2018, LG Chem and Samsung SDI ranked 4th and 6th
Based on Jan - Apr shipment record, Kia Motors Remain on Top 10 in Global PHEV Power Brands Ranking
Consumer Prices for May 2018
Producer Prices for the Industrial Sector for May 2018
Industrial Production Operation in May 2018
Investment in Fixed Assets for the First Five Months of 2018
National Real Estate Development and Sales in the First Five months of 2018
Producer Prices for the Industrial Sector for April 2018
Stable Performance for the National Economy in April
Total Retail Sales of Consumer Goods in April 2018
Industrial Production Operation in April 2018
National Real Estate Development and Sales in the First four months of 2018
Sales Prices of Residential Buildings in 70 Medium and Large-sized Cities in April 2018
Industrial Profits Increased in the First Four Months of 2018
Industry News
  More>>
Iron and steel sector gains strength
China’s wines take center stage
Machinery manufacturing fair boosts Sino-Russian ties
Medical device manufacturers display their latest technology
Soybean farmers store crops amid hopes of higher prices
Tourism industry opening on agenda
Tech competition eases startups' access to China market
China's excavator sales grow 44.9% in October
China's solid waste imports continue to slump on tightened ban
Delivery orders jump 25.12% to 1.35b on Singles Day
Related Links
Initiative helps boost traditional Chinese medicine
Traditional Chinese medicine exports rebound in 2017
Foci Pharmaceutical Company applies for EU product license
TCM's increasing price has many concerned
2011 Q1 Nutrastar International Inc.net revenue rises 21.6%
TCM gains ground in Denmark
Traditional Chinese medicine seeking greater global recognition

Sitemap       |       Join Us      |       Customer Service       |       About Sino-report
Copyright © 2011-2025 Sino-report Consult Inc.
Sino-report@hotmail.com    Postmaster@sino-report.com
No.18 Zhichun Road, Haidian District. Beijing 100089.China
Information and data contained in this site is for reference only pursuant to operate your own risk
Sino-report